Tribunal overturns Income Tax Commissioner's order for A.Y. 2016-17 & 2017-18, upholds original assessment.

The Tribunal quashed the Principal Commissioner of Income Tax's order under Section 263 for A.Y. 2016-17 and 2017-18, upholding the original assessment orders. It found that the Assessing Officer had conducted detailed inquiries and the claims for depreciation on goodwill and deduction under Section 35(2AB) were justified based on substantial documentation and legal precedents. The appeals were allowed in favor of the assessee.

---

---

Issues Involved:
1. Validity of the order passed under Section 263 of the Income Tax Act.
2. Claim of depreciation on goodwill arising from amalgamation.
3. Claim of deduction under Section 35(2AB) for Research & Development (R&D) expenditure.

Issue-wise Detailed Analysis:

1. Validity of the order passed under Section 263 of the Income Tax Act:
The Principal Commissioner of Income Tax (Pr. CIT) invoked Section 263, stating that the assessment orders for A.Y. 2016-17 and 2017-18 were erroneous and prejudicial to the interest of the revenue. The Pr. CIT argued that the Assessing Officer (AO) had not made proper inquiries regarding the depreciation on goodwill and the deduction claimed under Section 35(2AB). However, the Tribunal found that the AO had indeed made detailed inquiries and obtained substantial documentation from the assessee during the original assessment proceedings. The Tribunal emphasized that merely because the AO did not discuss these inquiries in the assessment order does not render the order erroneous. The Tribunal concluded that the Pr. CIT failed to demonstrate how the AO's order was prejudicial to the revenue, thus quashing the order under Section 263.

2. Claim of depreciation on goodwill arising from amalgamation:
The assessee claimed depreciation on goodwill arising from the amalgamation of Troikaa Pharmaceuticals Ltd. with Troikaa Exports Pvt. Ltd. The Pr. CIT contended that the goodwill was artificially created in the books of the amalgamated company and was not eligible for depreciation. The Tribunal referred to the Supreme Court's decision in CIT vs. Smifs Securities Ltd., which held that goodwill is an asset under Explanation 3(b) to Section 32(1) and is eligible for depreciation. The Tribunal also noted that the assessee had followed the purchase method of accounting as per Accounting Standard 14, which justified the recognition of goodwill. The Tribunal concluded that the AO had rightly allowed the depreciation on goodwill.

3. Claim of deduction under Section 35(2AB) for Research & Development (R&D) expenditure:
The assessee claimed weighted deduction under Section 35(2AB) for R&D expenditure. The Pr. CIT argued that the AO allowed excess deduction without proper verification, especially since the Department of Scientific and Industrial Research (DSIR) approved a lower amount of eligible expenditure. The Tribunal found that the AO had issued multiple notices and made detailed inquiries regarding the R&D expenditure during the assessment proceedings. The Tribunal also referred to judicial precedents, including the Gujarat High Court's decision in CIT vs. Cadila Healthcare Ltd., which allowed weighted deduction for clinical trial expenditure conducted outside the approved facility. The Tribunal noted that the AO had restricted the deduction to the amount approved by DSIR, aligning with the amended provisions effective from 1-7-2016. The Tribunal concluded that the AO's order was neither erroneous nor prejudicial to the revenue.

Conclusion:
The Tribunal quashed the Pr. CIT's order under Section 263 for both A.Y. 2016-17 and 2017-18, upholding the AO's original assessment orders. The Tribunal found that the AO had made proper inquiries and allowed the claims based on substantial documentation and judicial precedents. The appeals were allowed in favor of the assessee.

---